WALDENSTROM MACROGLOBULINAEMIA
Clinical trials for WALDENSTROM MACROGLOBULINAEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM MACROGLOBULINAEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR T-Cell therapy aims to tackle tough lymphoma
Disease control Recruiting nowThis early-stage study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to better recognize and attack cancer cells. T…
Matched conditions: WALDENSTROM MACROGLOBULINAEMIA
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 17, 2026 01:48 UTC
-
New study aims to stop nerve damage in rare blood cancer
Knowledge-focused Recruiting nowThis study looks at why people with Waldenström's macroglobulinemia (a rare blood cancer) often develop nerve damage, causing pain, numbness, and trouble moving. Researchers will examine 90 adults with symptoms to find the exact cause and see if early treatment can prevent lastin…
Matched conditions: WALDENSTROM MACROGLOBULINAEMIA
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 17, 2026 01:47 UTC